DISCIPLINE RECORD/ COURSE / SEMINAR DESCRIPTION

Size: px
Start display at page:

Download "DISCIPLINE RECORD/ COURSE / SEMINAR DESCRIPTION"

Transcription

1 Universitatea de Medicină şi Farmacie Grigore T. Popa Iaşi Comisia pentru asigurarea calităţii DISCIPLINE RECORD/ COURSE / SEMINAR DESCRIPTION 1. Information about the program UNIVERSITY: GRIGORE T. POPA UNIVERSITY OF MEDICINE AND PHARMACY OF 1.1. IAŞI 1.2. FACULTY: PHARMACY SCHOOL / DEPARTMENT: PHARMACEUTICAL SCIENCES II 1.3. SUBJECT: INDUSTRIAL PHARMACEUTICAL TECHNOLOGY 1.4. STUDY FIELD: PHARMACY 1.5. STUDY CYCLE: UNDERGRADUATE 1.6. STUDY PROGRAMME: IN ENGLISH 2. Subject data 2.1. SUBJECT: INDUSTRIAL PHARMACEUTICAL TECHNOLOGY 2.2. Module leader: Lecturer Carmen Gafitanu, PhD, Assoc. Prof. Gratiela Popa, PhD 2.3. Seminar leader: Lecturer Carmen Gafitanu, PhD, Assoc. Prof. Gratiela Popa, PhD, Assist. Andreea 2.4. Year of study Creteanu, PhD V 2.5. Semester in which is taught I 2.6. Evaluation type 3. Duration of the course (hours per semester) E Subject status Compulsory 3.1. Number of hours Number of Seminar / lab 3 / week hours / week 3.4.Total number of learning hours Total number of learning hours seminar / lab Distribution of activities in the course hours Study based on the manual, printed course, bibliography and notes 5 Additional research in the library, on specialized e-platforms and field study 5 Preparation for seminars, practical courses, portfolios and essays 10 Tutoring 10 Assessment - Other activities Number of hours of individual study Number of hours per semester Number of ECTS 4 4. Previous Knowledge (if applicable) 4.1. course related Pharmaceutical Propaedeutics, Physical Chemistry, Pharmaceutical Technology (3 rd and 4 th year of study, homogenous and heterogenous pharmaceutical dosage forms) skill related - notions about the homogenous and microheterogenous pharmaceutical dosage forms; - basic notions on formulation, preparation and quality control of pharmaceutical dosage forms.

2 5. Requirements (if applicable) 5.1. course conditions Video projector, work sheets, flip chart seminar / laboratory conditions Laboratory glassware, specific compounding tools, active drugs and excipients, laboratory-scale equipments for dosage forms preparation (pharmaceutical standard sieves, semi-automatic capsule filling apparatus, tablet press) ; devices for the quality control of pharmaceutical dosage forms. 6. Specific Skills Acquired Professional skills displayed by knowledge and skills Transversal skills (role skills, professional and personal skills) Design, formulation, industrial manufacture and packaging of medicines and dietary supplements. Storage, preservation and distribution of industrially manufactured medicines and dietary supplements. Quality control of medicines, dietary supplements, cosmetics and other health care products. Consultancy and expertise in the field industrial manufacture of medicines. Valorization of the acquired theoretical knowledge and adaptation to the requirements of the pharmaceutical industry. Communication skills (oral and in writing) specific to the pharmaceutical profession. Autonomy and resonsibility in taking professional decisions. 7. Course Objectives (confirmed by the grid of specific skills acquired) 7.1. General Objective Knowledge of the main important steps involved in the industrial design and manufacture of drugs: specific guidances for industry, preformulation and formulation aspects, industrial manufacture flow of dosage forms Specific Objectives Knowledge of solid oral dosage forms manufactured in the industry: medicated powders, capsules, granules, tablets, modified-release solid dosage forms. 8. Contents 8.1. Course Teaching methods Observations Manufacture steps of the industrial dosage forms Research and development: pilot scale manufacture and scale-up 2 hours steps; industrial manufacture of dosage forms. Definition, components and characteristics of the pharmaceutical industry, global concept of a pharmaceutical manufacturing plant. Essential elements in the quality of drug products: the four M concept: personnel (men), raw materials, machinery and methods. Industrial packaging, storage and shelf life of an industrial dosage form. Quality assurance and Good Manufacturing Practice in the pharmaceutical industry. Validation Solid dosage forms as heterogeneous disperse systems Dosage forms composed of individual particles -Powders: definition, advantages and limitations, types of powders, formulation goals. Pharmacopoeial standards. Factors influencing powder formulation. Powder properties. 8 hours

3 -Structural and dimensional properties: shape, particle size and diameter, size distribution of particles in a powder bed; density of powders. Electrical properties, superficial properties, mechanical properties, flow properties (rheology of powders). Technological properties influencing formulation; raw materials for powders: drugs, excipients. -Manufacture technology of powders: unit operations. Drying of solids; heat transfer methods: air circulation drying, conduction (hot surface) drying, radiation drying, microwave drying, drying of diluted solutions and suspensions, freeze-drying. Particle size reduction: methods and equipments for cutting and grinding; equipments for particle size reduction: mills. Powder sieving; pharmaceutical sieves: classification and characterization according to Pharmacopoeias; factors influencing powder sieving. Mixing of powders: mechanisms, mixing equipments. Technology of powders: clean rooms; manufacture steps. Quality assurance and control of powders. Encapsulated dosage forms -Definition, advantages, limitations, types of capsules. Starch capsules. Hard gelatin capsules: types, formulation, raw materials. Industrial manufacture: capsule wall, capsule content. Small scale filling of hard gelatin capsules (laboratory scale and pharmacy scale). -Industrial filling of hard gelatin capsules: equipments. Bioavailability, quality assurance and control of hard gelatin capsules. -Soft gelatin capsules. Formulation of content. Industrial manufacture: methods, equipments. Packaging and storage, quality assurance and control, bioavailability of soft gelatin capsules. Solid dosage forms made by aggregation and agglomeration of particles -Medicated gums. Soft lozenges. Hard candy lozenges. Medicated lollipops. Molded tablets. Medicated chocolates. -Granules: definition, advantages and limitations, formulation. Mechanisms of granulation. Raw materials. Industrial manufacture: dry granulation method. -Wet granulation methods: conventional wet granulation, high shear granulation, fluidized bed granulation, centrifugal bed granulation, spray drying granulation. Problems of granule drying: solvent migration. Packaging, storage, quality assurance and control. Bioavailability of granules. -Pellets definition, advantages, limitations. Formulation of pellets. Industrial methods: extrusion-spheronization, powder coating, centrifugal fluidization, liquid spray coating, spray congealing, meltextrusion. Quality assurance and control of pellets. Solid dosage forms made by agglomeration and compaction -Tablets definition, advantages, limitations; types of tablets, formulation. Desired characteristics for tabletting: compressibility, powder flow. Evaluation of compression behavior of powders and granules. -Physics of the compression process: factors influencing compaction and compression. Raw materials for tablet manufacture; excipients: fillers, binders, disintegrants, superdisintegrants, lubricants, glidants, 4 hours 5 hours 5 hours

4 other excipients. Manufacturing steps: compression cycle. -Tablet presses: types; tabletting steps through various methods: direct compression and indirect compression (dry granulation and wet granulation). Packaging and storage, quality assurance and control. Bioavailability of tablets. -Special formulations of fast release tablets: effervescent tablets, orally disintegrating tablets, sublingual tablets. -Tablets for other administration routes: vaginal, implantable tablets. Coated solid dosage forms -Definition, advantages, limitations, types of coating, formulation. Mechanisms of film formation, principles of coating. Coating technologies: equipments, methods. -Sugar coating, steps of industrial process. Film coating of tablets, press coarting, melt coating. Packaging and storage, quality assurance and control, bioavailability of coated dosage forms. Modified release dosage forms -Prolonged release dosage forms: formulation, manufacture. Sustained release, sequential release, controlled release dosage forms (tablets, capsules): reservoir systems, matrix systems, osmotic systems, gastroretentive systems, floating systems, bioadhesive systems. Targeted release systems. Video projections, (short Video projections, (short 2 hours 2 hours -Microcapsules, nanocapsules. Bibliography 1. Delivery Systems. 10th Edition. Allen LV, Ansel HC (editors). Lippincott, Williams & Wilkins, Popovici I, Lupuleasa D. Pharmaceutical Technology. 3 rd Edition, vol. I. Iasi: Polirom Publishing House, Popovici I, Lupuleasa D. Pharmaceutical Technology. Vol. III. Iasi: Polirom Publishing House, Leucuta S. Industrial Pharmaceutical Technology. Cluj-Napoca: Dacia Publishing House, Swarbrick J, Boylan JC. Encylopedia of Pharmaceutical Technology. New York: Ed. M. Dekker Inc., vol. I-IV, ***The Romanian Pharmacopoeia, 10 th Edition, 1993 and Supplements Bucharest: Medical Publishing House Seminar / Practical lessons Teaching Methods Observations 1. Solid dosage forms as macro-heterogeneous disperse systems Oral solid dosage forms. Pharmaceutical powders. Preparation, unit operations: drying, grinding/particle size reduction, sieving, mixing of powders 2. Powders -Pharmacopoeial standards: monographs in the Romanian Pharmacopoeia 10 th edition, European Pharmacopoeia 7 th edition; single active drug powders; packaging, storage and quality control. Compounding powders: bulk powders and divided powders; powders with different apparent densities, magistral preparations. -Multiple active drug powders (bulk powders): compounded and officinal preparations containing substances with water of hydration. Hygroscopic powders and eutectic mixture formation in powders. Industrial products: examples. -Powders with potent active drugs: controlled drugs (addictive, toxic drugs). Calculations of maximum therapeutic doses. Powders Performing the studied unit operations in laboratoryscale; Compounding the studied magistral examples; the studied topic. 3 hours 15 hours

5 containing coloured substances. -Powders containing lipophilic active drugs, volatile oils and substances. Industrial products: examples. -Topical powders- magistral and industrial examples. Quality control of powders, rheological behavior. 3. Capsules -Monographs in the Romanian Pharmacopoeia 10 th edition and Supplement Preparation of soft gelatin capsules by immersion method. Soft gelatin capsules containing lipophilic vitamins. Industrial examples. -Hard gelatin capsules laboratory scale filling of capsules using the Feton apparatus. Industrial examples of hard gelatin capsules. Quality control of capsules: in vitro disintegration test for soft and hard gelatin capsules. Laboratory-scale filling of hard gelatine capsules (using the Feton apparatus); 4. the studied topic. 5. Granules. Molded tablets. Lozenges -Granules Monographs in the Romanian Pharmacopoeia 10 th edition and Supplement Formulation, laboratory scale preparation of granules by conventional wet granulation method. Industrial and Laboratory-scale magistral examples of granules. preparation of granules; -Quality control of granules, in vitro disintegration test. Molded tablets, lozenges, medicated chocolates formulation, preparation methods, industrial examples. 6. Tablets -Monographs in the Romanian Pharmacopoeia 10 th edition, European Pharmacopoeia 7 th edition. Preparation of tablets by direct compression. Industrial examples. -Evaluation of compression and rheological properties of raw materials used in the preparation of tablets (via direct compression or with prior granulation): particle shape and size, flow speed, angle of repose, apparent volume, bulk density, tapped density of powders and granules. Hausner ratio, Carr index. -Preparation of tablets via indirect compression method: compression of granules obtained by wet granulation; drying, sieving and lubrication of granules. -Coated tablets: types, industrial examples. Quality control of tablets prepared in the laboratory and of industrial products. Disintegration test and dissolution test. 7. Interactions occurring in pharmaceutical dosage forms -Drug interactions and ways of avoiding them. Magistral formulations containing solid industrial products. the studied topic. Laboratory-scale compression of tablets on a single-punch tablet press; the studied topic the studied topic 6 hours 6 hours 9 hours 3 hours Bibliography 1. Delivery Systems. 10th Edition. Allen LV, Ansel HC (editors). Lippincott, Williams & Wilkins, Popovici I, Lupuleasa D. Pharmaceutical Technology. Vol. III. Iasi: Polirom Publishing House, Swarbrick J, Boylan JC. Encylopedia of Pharmaceutical Technology. New York: Ed. M. Dekker Inc., vol. I-IV, ***The Romanian Pharmacopoeia. 10 th Edition and Supplements Bucharest: Medical

6 Publishing House. 9. The agreement between the course contents and the expectations of the representatives of the epistemic communities, professional associations and employers in the field related to the program - Implementing the practical notions in the pharmaceutical compounding activity; - Correlating the theoretical notions with the specific requirements of industrial manufacturing of dosage forms. 10. Assessment Activity Assessment criteria Assessment methods Percentage of the final grade Course Knowledge of the notions Final exam at the end of 50% taught in course the semester; Seminar / Practical Activity of the student Written tests, oral 15% lessons during the semester assessment; Knowledge of the practical notions taught during the lab classes; Final practical exam; 35% Minimal standard of proficiency Promoting the exam with a minimum grade of 5 (on a scale of 1 to 10). Date: Signature of Coordinator for Teaching Activities Prof. Ilena Cojocaru, PhD Assoc. Prof. Gratiela Popa, PhD Lecturer Carmen Gafitanu, PhD Date of indorsement in the Council of the Department Signature of The Department Director Prof. Anca Miron, PhD

KING KHALID UNIVERSITY

KING KHALID UNIVERSITY KING KHALID UNIVERSITY COLLEGE OF PHARMACY DEPARTMENT OF PHARMACEUTICS COURSE SCHEDULE MALE SECTION SOLID DOSAGE FORMS FOR PHARMACEUTICAL SCIENCES/CLINICAL PHARMACY BY PROF DR MOHAMED FATHY Academic Session

More information

DISCIPLINE RECORD/ COURSE / SEMINAR DESCRIPTION

DISCIPLINE RECORD/ COURSE / SEMINAR DESCRIPTION Universitatea de Medicină şi Farmacie Grigore T. Popa Iaşi Comisia pentru asigurarea calităţii DISCIPLINE RECORD/ COURSE / SEMINAR DESCRIPTION 1. Information about the program UNIVERSITY: GRIGORE T. POPA

More information

REVISION OF MONOGRAPH ON TABLETS. Tablets

REVISION OF MONOGRAPH ON TABLETS. Tablets March 2011 REVISION OF MONOGRAPH ON TABLETS Final text for addition to The International Pharmacopoeia This monograph was adopted by the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical

More information

Easy, fast and reliable!

Easy, fast and reliable! Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. Tailormade formulated. s film coating products are one-step coating

More information

Easy, fast and reliable!

Easy, fast and reliable! Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. s film coating products are one-step coating systems for pharmaceutical

More information

Factors responsible for the impaired bioavailability and instability rifampicin FDC

Factors responsible for the impaired bioavailability and instability rifampicin FDC Table of contents 1.0 Introduction 1.1 Oral multiparticulate drug delivery system...2 1.2 Methods of preparing pellets...3 1.3 Extrusion-spheronization...3 1.4 Theory of pellet formation and growth...4

More information

Drug Development by Government Pharmaceutical Organization. Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand

Drug Development by Government Pharmaceutical Organization. Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand Drug Development by Government Pharmaceutical Organization Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand 20August 2012 GPO s Profile GPO was established in 1966.

More information

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Ali Y Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School of Pharmacy University of Sulaimani 09/01/2019

More information

Technical brochure StarLac

Technical brochure StarLac T R TABLETING AC DIRECT COMPRESSION CO-PROCESSED LACTOSE Technical brochure MEGGLE co-processed lactose grades for direct compression: General information Direct compression (DC) tablet manufacture is

More information

OCE TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE. Technical brochure MicroceLac 100

OCE TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE. Technical brochure MicroceLac 100 IC OCE TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE AC Technical brochure MEGGLE co-processed lactose grades for direct compression: General information Direct compression (DC) tablet manufacture

More information

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products 57. Starch Convention, Detmold, April 26-28, 2006 K.-J. Steffens Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products Starches, Pharmaceutical Applications _ Starches

More information

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients LubriTose Mannitol Michael Crowley, Director of R&D, Excipients Introduction Michael Crowley Director of R&D Excipients 158 St. Highway 320 Norwich, NY 13815 PH 315-802-5970 Michael.Crowley@Kerry.com 2

More information

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies VIVAPHARM PVP/VA Copovidone, Ph.Eur. USP/NF, JPE, E 1208, FCC The Ultimate Tablet Binder for All Processing Technologies Direct Compression Dry Granulation Hot Melt Extrusion Wet Granulation VIVAPHARM

More information

Formulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride.

Formulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride. Available online on www.ijcpr.com International Journal of Current Pharmaceutical Review and Research, 3(4), 105-109 Research Article ISSN: 0976-822X Formulation and Evaluation of Gastroretentive Dosage

More information

FORMULATION CHOICE. How and why they are chosen. Dr Andy Fowles On behalf of ECPA Specification Expert Group

FORMULATION CHOICE. How and why they are chosen. Dr Andy Fowles On behalf of ECPA Specification Expert Group FORMULATION CHOICE How and why they are chosen Dr Andy Fowles On behalf of ECPA Specification Expert Group Topics Why formulate? How to identify formulation options Drivers Principle formulation type overview

More information

REGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore

REGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore 1 REGULATORY PERSPECTIVE Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore Contents 2 1. Role of Dissolution Testing in Generic Drug Approval 2. Dissolution Testing Recommendation for Solid Oral

More information

The unlocked synergy of DFE Pharma MCC

The unlocked synergy of DFE Pharma MCC The unlocked synergy of DFE Pharma MCC We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder inhalation formulations.

More information

FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels

FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels Seite 1 von 8 Share this story: Issue: April 2015, Posted Date: 3/30/2015 FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels INTRODUCTION Soft gelatin capsules (softgels) continue

More information

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION 1 PHARMACEUTICS Pharmaceutics is the science of dosage form design. The general area of study concerned with the formulation, manufacture, stability, and

More information

AUSTRALIAN MADE CAMPAIGN LIMITED

AUSTRALIAN MADE CAMPAIGN LIMITED AUSTRALIAN MADE CAMPAIGN LIMITED PHARMACEUTICALS AND COMPLEMENTARY HEALTHCARE PRODUCTS - COMPLIANCE POLICY May 2018 Summary Made Campaign Limited (AMCL) is the t-for-profit organisation which administers

More information

Food supplement manufacture

Food supplement manufacture Food supplement manufacture Nick Bennett BSc. RNutr April 2018 1 Introduction There are many different product formats available Liquids, powders, tablets, capsules etc Many different types of machine

More information

International Journal of Innovative Pharmaceutical Sciences and Research

International Journal of Innovative Pharmaceutical Sciences and Research International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com FORMULATION AND EVALUATION OF MODIFIED REALEASE CAPSULES OF BUDESONIDE 1 K.Veera Kumari*, 2 Dr. Appa Rao, 3 Dr.Shaik.Harun

More information

Principals and Dosage Forms in the Therapy Modified Drug Release. Institute of Pharmaceutical Technology and Biopharmacy

Principals and Dosage Forms in the Therapy Modified Drug Release. Institute of Pharmaceutical Technology and Biopharmacy Principals and Dosage Forms in the Therapy Modified Drug Release Institute of Pharmaceutical Technology and Biopharmacy Dosage forms Definition: Dosage forms are the means by which drug molecules are delivered

More information

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

Formulation and Development of Sustained Release Tablets of Valsartan Sodium INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Research Article Formulation and Development of Sustained Release Tablets of Valsartan Sodium G. Sandeep * and A. Navya Department of

More information

STARCH Application Data

STARCH Application Data STARCH 1500 Application Data Partially Pregelatinized Maize Starch Starch 1500, Partially Pregelatinized Maize Starch, Used as a Binder Disintegrant in High Shear Wet Granulation Comparison to Povidone

More information

Design and development of fast Melting Tablets of Terbutaline Sulphate

Design and development of fast Melting Tablets of Terbutaline Sulphate Design and development of fast Melting Tablets of Terbutaline Sulphate Mathew T and Agrawal S Swami Vivekanand College of Pharmacy, Khandwa Road, Indore (MP), INDIA Available online at: www.isca.in (Received

More information

SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING

SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING Dr. Dieter Lubda MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany Agenda: Sustained release

More information

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant EXCIPIENTS STARCH 1500 Proven and Trusted Excipient for Performance and Versatility Effective and economical disintegrant Excellent stability for moisture sensitive drugs Manufactured exclusively for the

More information

University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester

University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester 5/21/2017 Pharmaceutical Compounding, Dr. rer. nat. Rebaz Ali 1 Outlines Why rectal or vaginal route? Suppository

More information

Leader in custom manufacturing. for the pharmaceutical and nutraceutical industries.

Leader in custom manufacturing. for the pharmaceutical and nutraceutical industries. Leader in custom manufacturing for the pharmaceutical and nutraceutical industries. Since its inception in April 1994, Viva Pharmaceutical Inc. has built a reputation as a leading manufacturer committed

More information

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007) November 2007 LIQUID PREPARATIONS FOR ORAL USE Final text for addition to The International Pharmacopoeia (November 2007) This monograph was adopted at the Forty-second WHO Expert Committee on Specifications

More information

Contract Manufacturing Fluid Bed Technology. Drying. Spray granulation. Coating. Agglomeration. Instantization.

Contract Manufacturing Fluid Bed Technology. Drying. Spray granulation. Coating. Agglomeration. Instantization. Contract Manufacturing Fluid Bed Technology Drying. Spray granulation. Coating. Agglomeration. Instantization. Multifunctional fluid bed processor State-of-the-art fluid bed technology for a diversity

More information

Formulation and evaluation of oro-dispersible tablets of lafutidine

Formulation and evaluation of oro-dispersible tablets of lafutidine Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):226-235 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good

Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good TABLET PRODUCTİON Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good quality at high standards. Based on preformulation

More information

The binding performance of DFE Pharma Starch

The binding performance of DFE Pharma Starch The binding performance of DFE Pharma Starch MCC Starch Lactose Inhalation Superdisintegrants We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients

More information

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN Int. J. Chem. Sci.: 10(4), 2012, 2199-2208 ISSN 0972-768X www.sadgurupublications.com DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN K. V. R. N. S. RAMESH *, B. HEMA KIRNAMAYI

More information

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009 Co-Processed Excipients: Regulatory Challenges Carl Mroz Colorcon Limited June 2009 What is a Co-Processed excipient? Several types of excipient contain multiple components by design Use of processing

More information

Pharmaceutical Preparation For Internal Use

Pharmaceutical Preparation For Internal Use Pharmaceutical Preparation For Internal Use 1. Solid Preparations (Tablet, Capsule, Pill) 2. Liquid Preparations (Aqua, Syrup, Elixir, Extract, Liquor, Emulsion, Mixture, Infusion, Decoction). 3. Powder

More information

Challenges and solutions for moisture sensitive API formulation

Challenges and solutions for moisture sensitive API formulation Challenges and solutions for moisture sensitive API formulation Introduction Today, formulators are looking for alternative processes to reformulate existing products or to formulate New Chemical Entities

More information

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY Excipients are inactive ingredients used as carriers for the active ingredients in a pharmaceutical product. These may

More information

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION LEARNING OBJECTIVES The objectives of this unit are to: Understand the formulation of solid dosage form. Understand the characteristic

More information

Commercial Bulleting Aloe Flakes

Commercial Bulleting Aloe Flakes Commercial Bulleting Aloe Flakes Be a Pioneer using Aloe Vera Flakes in food and beverage industry AMB s exclusive Aloe Flakes demonstrates superior solubility retaining the highest percentage of the benefical

More information

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL VOLUME 2C. Guidelines. Medicinal products for human use

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL VOLUME 2C. Guidelines. Medicinal products for human use EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Brussels, March 2018 SANTE-2017-11668 Revision 2 NOTICE TO APPLICANTS VOLUME 2C Guidelines Medicinal products for human use Safety, environment

More information

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose 1 Pharmaceutical industry borrowed ingredients from other industries Food Cosmetic Industrial Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work that has all changed

More information

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO: LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,

More information

FLAVOUR FLOW & ADHESION

FLAVOUR FLOW & ADHESION FLAVOUR FLOW & ADHESION Nicole Bruyndonckx GRIFFITH FOODS Dry Seasonings Global manufacturer of savoury food ingredients since 1919 Sauces & Marinades Canada USA Mexico Costa Rica Colombia United Kingdom

More information

LAB.2. Tablet Production Methods

LAB.2. Tablet Production Methods LAB.2 Tablet Production Methods Dry methods Direct compression Dry granulation Wet methods Wet granulation Regardless whether tablets are made by direct compression or granulation, the first step, milling

More information

DESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG

DESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article DESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG M Seth *, DS Goswami,

More information

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Dr. Susanne Keitel Director EDQM, Council of Europe Outline 1. The European Pharmacopoeia 2. The importance of

More information

Technical brochure CombiLac

Technical brochure CombiLac OM I AC TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE Technical brochure MEGGLE co-processed lactose grades for direct compression: General information Direct compression (DC) tablet manufacture is

More information

Formulation and evaluation of sublingual tablets of lisinopril

Formulation and evaluation of sublingual tablets of lisinopril Journal of GROVER Scientific & Industrial AGARWAL: Research FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS OF LISINOPRIL Vol. 71, June 2012, pp. 413-417 413 Formulation and evaluation of sublingual tablets

More information

International Journal of PharmTech Research

International Journal of PharmTech Research International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: 0974-4304 Vol.8, No.3, pp 371-376, 2015 Application of Cow Ghee as an excipient in Hot Melt Coating agent in controlled release rifampicin

More information

FORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN

FORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN FORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN Ms. Jyoti Rathore 1*, Mr. Hitesh Kumar Parmar 1 Ujjain Institute of Pharmaceutical Sciences, Ujjain. Email- hkparmar7@rediffmail.com ABSTRACT

More information

Available online through

Available online through Research Article Available online through www.ijrap.net DESIGN AND EVALUATION OF LOW COST DIRECTLY COMPRESSIBLE EXCIPIENTS Swamy P. V. *, Patil A. N., Shirsand S. B., Amitkumar T., Laeeq Farhana H.K.E

More information

Available online Research Article

Available online   Research Article Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 26, 8(2):7-7 Research Article ISSN : 975-7384 CODEN(USA) : JCPRC5 Optimization of directly compressible mixtures of microcrystalline

More information

Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives

Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives 2.1 Introduction According to the Food Protection Committee of the Food and Nutrition Board, food additives

More information

Formulation and evaluation of immediate release salbutamol sulphate

Formulation and evaluation of immediate release salbutamol sulphate 5 Formulation, optimization and evaluation of immediate release layer of salbutamol sulphate Salbutamol is moderately selective beta (2)-receptor agonist similar in structure to terbutaline and widely

More information

USP Chewable Gels Monographs

USP Chewable Gels Monographs USP Dietary Supplements Stakeholder Forum Tuesday, May 15, 2018 USP Chewable Gels Monographs Natalia Davydova, Ph.D. Scientific Liaison DS Gummies Market Value of the gummy vitamins market in the United

More information

OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105

OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105 Digest Journal of Nanomaterials and Biostructures Vol. 9, No. 3, July September 2014, p. 1077-1084 OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105

More information

SENTRY TM POLYOX Water Soluble Resins

SENTRY TM POLYOX Water Soluble Resins SENTRY TM POLYOX Water Soluble Resins Technical Information on Stability Introduction Key Points Antioxidants SENTRY POLYOX WSR resins consist of a family of high molecular weight polyethers with nominal

More information

AMENDMENTS TO THE SECOND REVISION OF THE FIRST EDITION OF THE MANUAL ON DEVELOPMENT AND USE OF FAO AND WHO SPECIFICATIONS FOR PESTICIDES

AMENDMENTS TO THE SECOND REVISION OF THE FIRST EDITION OF THE MANUAL ON DEVELOPMENT AND USE OF FAO AND WHO SPECIFICATIONS FOR PESTICIDES AMENDMENTS TO THE SECOND REVISION OF THE FIRST EDITION OF THE MANUAL ON DEVELOPMENT AND USE OF FAO AND WHO SPECIFICATIONS FOR PESTICIDES Page Current text Revised text Notes P.21 A. 10.1. WHO classification

More information

Pharma & Food Solutions. POLYOX TM Water Soluble Resins Combining Flexibility with Consistency

Pharma & Food Solutions. POLYOX TM Water Soluble Resins Combining Flexibility with Consistency Pharma & Food Solutions POLYOX TM Water Soluble Resins Combining Flexibility with Consistency POLYOX 9-13 POLYOX 9-13 POLYOX * are nonionic poly (ethylene oxide) polymers that meet all the specifications

More information

FAO SPECIFICATIONS FAO PLANT PROTECTION PRODUCTS SULPHUR. FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 1973

FAO SPECIFICATIONS FAO PLANT PROTECTION PRODUCTS SULPHUR. FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 1973 AGP: CP/58 FAO SPECIFICATIONS FAO PLANT PROTECTION PRODUCTS SULPHUR FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 1973 DISCLAIMER 1 FAO specifications are developed with the basic objective

More information

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications Hypromellose CONTENTS PAGE 2 Preface Matrix system Selection of METOLOSE grades Specifications Properties Powder Solution Application Related Patents 3 4-5 6 8 10 13 14 17 Please note: The information

More information

Decentralised Procedure. Public Assessment Report

Decentralised Procedure. Public Assessment Report Decentralised Procedure Public Assessment Report Venlafaxin ratiopharm Venlafaxin AbZ-Pharma Venlafaxin CT-Arzneimittel prolonged-release capsule hard venlafaxine hydrochloride DE/H/3393-3395/01-03/DC

More information

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017 Innovations in Design: NIA-West Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017 1 Innovations in Design: How Do You Stand Out? If all other competitors are the same

More information

COPYRIGHTED MATERIAL. Contents. xiv xv xvi. About the authors Preface Acknowledgments

COPYRIGHTED MATERIAL. Contents. xiv xv xvi. About the authors Preface Acknowledgments About the authors Preface Acknowledgments 1 Introduction to spray drying 1 1.1 Introduction 1 1.2 Stage 1: Atomization 2 1.2.1 Principle of atomization 3 1.2.2 Classification of atomizers 4 1.2.2.1 Rotary

More information

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process Direct With the right ingredients it s a simple, cost-effective manufacturing process TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Speed and savings sounds good to us

More information

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1 US 2003.01.18647A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0118647 A1 Seth (43) Pub. Date: (54) EXTENDED RELEASE TABLET OF Publication Classification METFORMIN (51)

More information

Granulation Aggregation

Granulation Aggregation Granulation Aggregation Wet granulation Solvent granulation (crust granules) Binder granulation (sticked granules) Granulation liquid Water Water + alcohol mixture Macromolecular colloidal solution i.e.:

More information

905 UNIFORMITY OF DOSAGE UNITS

905 UNIFORMITY OF DOSAGE UNITS Change to read: 905 UNIFORMITY OF DOSAGE UNITS [ NOTE In this chapter, unit and dosage unit are synonymous. ] To ensure the consistency of dosage units, each unit in a batch should have a drug substance

More information

Critical material properties for the design of robust drug products : excipient functionality related characteristics

Critical material properties for the design of robust drug products : excipient functionality related characteristics Critical material properties for the design of robust drug products : excipient functionality related characteristics Dr Liz Meehan, Pharmaceutical Development, Macclesfield UK 1 Excipients Definition

More information

Asian Journal of Biochemical and Pharmaceutical Research

Asian Journal of Biochemical and Pharmaceutical Research ISSN: 2231-2560 Research Article Asian Journal of Biochemical and Pharmaceutical Research Design and Evaluation of Gastroretentive Floating Tablets of Dipyridamole: Influence of Formulation Variables A.

More information

ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section.

ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section. 2. EXCIPIENTS PROFILES ANNEXURE -2 Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section. 2.1. COMPRITOL 888 Non proprietary names BP:

More information

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe General Concepts in the European Pharmacopoeia Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe General notices Anne-Sophie Bouin, 28/10/09 2009 EDQM, Council of Europe, All

More information

Design and In-vitro Evaluation of Silymarin Bilayer Tablets

Design and In-vitro Evaluation of Silymarin Bilayer Tablets CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original Article Design and In-vitro Evaluation of Silymarin

More information

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries. Technical Information Kolliwax HCO September 2015 03_150617e_00/Page 1 of 8 WF-No. 129938 = Registered trademark in many countries Hydrogenated castor oil powder for pharmaceutical use 03_150617e_00 September

More information

The influence of lactose particle size on dry powder inhalation performance

The influence of lactose particle size on dry powder inhalation performance The influence of lactose particle size on dry powder inhalation performance MCC Starch Lactose Inhalation Superdisintegrants 1 Introduction In most dry powder inhalation (DPI) formulations carriers are

More information

TABLET DESIGN AND FORMULATION

TABLET DESIGN AND FORMULATION TABLET DESIGN AND FORMULATION PART 5 Industrial pharmacy 5th class 1st semester TABLET DESIGN AND FORMULATION Conventional oral tablets for ingestion usually contain the same classes of components in addition

More information

Addendum to the 2016 FAO/WHO Manual on pesticide specifications: revised Tablet Specifications for DT, ST and WT

Addendum to the 2016 FAO/WHO Manual on pesticide specifications: revised Tablet Specifications for DT, ST and WT Addendum to the 2016 FAO/WHO Manual on pesticide specifications: revised Tablet Specifications for DT, ST and WT Introductory Note: The revised model specifications for tablets (ST, WT, DT) have been jointly

More information

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M. 61 East and Central African Journal of Pharmaceutical Sciences Vol. 18 (2015) 61-66 Short Communication Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L.

More information

IJRPC 2012, 2(3) Chowdary et al ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

IJRPC 2012, 2(3) Chowdary et al ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article PREPARATION, CHARACTERIZATION AND EVALUATION OF PGS - PVP CO-PROCESSED EXCIPIENT AS DIRECTLY

More information

Non-Food Uses of Polysaccharides

Non-Food Uses of Polysaccharides Non-Food Uses of Polysaccharides John Mitchell John.Mitchell@biopolymersolutions.co.uk Acknowledgements Fundamentals of Hydrocolloid Technology Course (2003-2009) Rob Winwood Colin Melia Steve Harding

More information

A. General Appearance

A. General Appearance TABLET EVALUATION To design tablets and later monitor tablet production quality, quantitative evaluations and assessments of a tablet s chemical, physical, and bioavailability properties must be made.

More information

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch Abstract K.P.R. Chowdary et al. / International Journal of Pharma Sciences and Research (IJPSR) Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch K.P.R. Chowdary*,

More information

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN: International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2014; 4(1):47-51 Research Article FORMULATION AND EVALUATION

More information

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS 211 7. SUMMARY, CONCLUSION AND RECOMMENDATIONS Drug absorption from the gastro intestinal tract can be limited by various factors with the most common one being poor aqueous solubility and poor permeability

More information

Formulation Development and Evaluation of Bilayer Floating Tablet of Antidiabetic Drugs

Formulation Development and Evaluation of Bilayer Floating Tablet of Antidiabetic Drugs Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 0, 8 ():- (http://scholarsresearchlibrary.com/archive.html) ISSN 097-07 USA CODEN: DPLEB Formulation

More information

Excipient Considerations for Continuous Manufacturing Implementation

Excipient Considerations for Continuous Manufacturing Implementation Excipient Considerations for Continuous Manufacturing Implementation FDA-PQRI Conference March 22-24, 2017 David R. Schoneker Director of Global Regulatory Affairs Email: dschoneker@colorcon.com 1 Continuous

More information

Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Studies on Carica Papaya Starch as a Pharmaceutical Excipient

Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Studies on Carica Papaya Starch as a Pharmaceutical Excipient Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2012, 4(6):3134-3138 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Studies on Carica Papaya Starch as a Pharmaceutical

More information

Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation

Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation Workshop on Paediatric Formulations For Assessors in National Regulatory Agencies

More information

372 J App Pharm Vol. 6; Issue 4: ; October, 2014 Moazzem et al, 2014

372 J App Pharm Vol. 6; Issue 4: ; October, 2014 Moazzem et al, 2014 372 J App Pharm Vol. 6; Issue 4: 372-379; October, 2014 Moazzem et al, 2014 Original Research Article EFFECT OF SUPERDISINTEGRATING AGENT ON THE RELEASE OF METFORMIN HCl FROM IMMEDIATE RELEASE TABLETS

More information

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS Int. J. Chem. Sci.: 8(1), 2010, 405-414 STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS V. L. NARASAIAH, T. KARTHIK KUMAR, D. SRINIVAS, K. SOWMYA, P. L. PRAVALLIKA and Sk. Md. MOBEEN

More information

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO: LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,

More information

FLORITER. New Technology for Innovative Formulation Design.

FLORITER. New Technology for Innovative Formulation Design. FLORITER New Technology for Innovative Formulation Design www.tomitaph.co.jp FLORITE Dramatically Change Your Formulation FLORITE is synthetic Calcium Silicate with exceptional liquid absorbency and excellent

More information

Why and how does a pharmaceutical company take the risk to use novel excipients?

Why and how does a pharmaceutical company take the risk to use novel excipients? Why and how does a pharmaceutical company take the risk to use novel excipients? M. Sherry Ku, Ph.D. CSO, Anchen Pharmaceuticals Irvine, CA Excipient Fest, May 5, 2010 Puerto Rico Global Excipient Acceptability

More information

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39 (19) (12) EUROPEAN PATENT APPLICATION (11) EP 2 233 131 A1 (43) Date of publication: 29.09. Bulletin /39 (1) Int Cl.: A61K 9/ (06.01) A61K 31/00 (06.01) (21) Application number: 09908.8 (22) Date of filing:

More information

Senior Scientist / Principal Scientist. Compounding Manager (Sterile and non-sterile specials) Senior Pharmaceutical Assessor

Senior Scientist / Principal Scientist. Compounding Manager (Sterile and non-sterile specials) Senior Pharmaceutical Assessor Curriculum Vitae PERSONAL INFORMATION Andrew Twitchell WORK EXPERIENCE May 1987 September 1991 Senior Scientist / Principal Scientist 3M Health Care Ltd, (United Kingdom) Formulation, scale-up and manufacture

More information

COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF

COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF A23G COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF Confectionery products, chocolate, cocoa products, chewing

More information

Formulation and Evaluation of Glicazide Mouth Dissolving Tablets

Formulation and Evaluation of Glicazide Mouth Dissolving Tablets Research Article Vishakha S. Hastak*, Yogyata S. Pathare, Kiran C. Mahajan Department of Pharmaceutics, Shree Chanakya Education Society's Indira college of Pharmacy, Tathawade, Pune, Maharashtra, India.

More information